Cargando…
11β-Hydroxysteroid Dehydrogenase Type 1 Regulates Glucocorticoid-Induced Insulin Resistance in Skeletal Muscle
OBJECTIVE: Glucocorticoid excess is characterized by increased adiposity, skeletal myopathy, and insulin resistance, but the precise molecular mechanisms are unknown. Within skeletal muscle, 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) converts cortisone (11-dehydrocorticosterone in rodents) t...
Autores principales: | Morgan, Stuart A., Sherlock, Mark, Gathercole, Laura L., Lavery, Gareth G., Lenaghan, Carol, Bujalska, Iwona J., Laber, David, Yu, Alice, Convey, Gemma, Mayers, Rachel, Hegyi, Krisztina, Sethi, Jaswinder K., Stewart, Paul M., Smith, David M., Tomlinson, Jeremy W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768185/ https://www.ncbi.nlm.nih.gov/pubmed/19675138 http://dx.doi.org/10.2337/db09-0525 |
Ejemplares similares
-
A novel selective 11β-hydroxysteroid dehydrogenase type 1
inhibitor prevents human adipogenesis
por: Bujalska, I J, et al.
Publicado: (2008) -
Lack of Significant Metabolic Abnormalities in Mice with Liver-Specific Disruption of 11β-Hydroxysteroid Dehydrogenase Type 1
por: Lavery, Gareth G., et al.
Publicado: (2012) -
Regulation of Lipogenesis by Glucocorticoids and Insulin in Human Adipose Tissue
por: Gathercole, Laura L., et al.
Publicado: (2011) -
Hydroxysteroid dehydrogenase HSD1L is localised to the pituitary–gonadal axis of primates
por: Bird, A Daniel, et al.
Publicado: (2017) -
Changes in 11β-Hydroxysteroid Dehydrogenase and Glucocorticoid Receptor Expression in Kawasaki Disease
por: Wang, Juanli, et al.
Publicado: (2017)